Tissue Regenix Group Stock Price, News & Analysis (LON:TRX)

GBX 8 0.00 (0.00 %)
(As of 02/19/2018 04:00 PM ET)
Previous CloseGBX 8
Today's RangeGBX 7.55 - GBX 8.50
52-Week RangeGBX 5.62 - GBX 19.50
Volume84,628 shs
Average Volume60,545 shs
Market Capitalization£84.83 million
P/E Ratio-800.00
Dividend YieldN/A
BetaN/A

About Tissue Regenix Group (LON:TRX)

Tissue Regenix Group logoTissue Regenix Group plc is a medical technology company. The Company is engaged in the development of regenerative products to make replacement native tissue using biological (human and animal) tissues. It operates through Cardiac, Wound Care and Orthopaedics divisions. Its decellularisation (dCELL) technology removes deoxyribonucleic acid and other cellular material from tissue leaving an acellular scaffold, which is not rejected by the patient's body. The dCELL has applications in wound care, heart valve replacement and knee repair. Its products portfolio includes DermaPure, which is used for the treatment of chronic or acute wounds; SurgiPure XD Surgical Tissue Matrix, which is used as a soft tissue patch for the surgical repair of damaged or ruptured soft tissue membranes; OrthoPure XM, which is used to replace the tissue removed during a partial meniscopy; OrthoPure XT, which is a decellurised porcine tendon, and CardioPure, a decellurised human pulmonary or aortic heart valve.

Receive TRX News and Ratings via Email

Sign-up to receive the latest news and ratings for TRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorHealthcare
SymbolLON:TRX
CUSIPN/A
Phone+44-1904-567609

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-800
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.01)
Net IncomeN/A
Net Margins-346.29%
Return on Equity-95.68%
Return on Assets-87.20%

Miscellaneous

EmployeesN/A
Outstanding Shares1,160,000,000

Tissue Regenix Group (LON:TRX) Frequently Asked Questions

What is Tissue Regenix Group's stock symbol?

Tissue Regenix Group trades on the London Stock Exchange (LON) under the ticker symbol "TRX."

Where is Tissue Regenix Group's stock going? Where will Tissue Regenix Group's stock price be in 2018?

2 brokers have issued 12 month target prices for Tissue Regenix Group's shares. Their predictions range from GBX 39 to GBX 39. On average, they expect Tissue Regenix Group's share price to reach GBX 39 in the next year. View Analyst Ratings for Tissue Regenix Group.

Who are some of Tissue Regenix Group's key competitors?

Who are Tissue Regenix Group's key executives?

Tissue Regenix Group's management team includes the folowing people:

  • John Samuel, Executive Chairman of the Board
  • Steven Ashley Couldwell, Chief Executive Officer, Director (Age 55)
  • Jonathan M. Glenn, Non-Executive Director (Age 47)
  • Randeep Singh Grewal, Non-Executive Director (Age 48)
  • Shervanthi Homer - Vanniasinkam, Non-Executive Director (Age 58)
  • Alan Miller, Non-Executive Director

How do I buy Tissue Regenix Group stock?

Shares of Tissue Regenix Group and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Tissue Regenix Group's stock price today?

One share of Tissue Regenix Group stock can currently be purchased for approximately GBX 8.

How big of a company is Tissue Regenix Group?

Tissue Regenix Group has a market capitalization of £84.83 million.

How can I contact Tissue Regenix Group?

Tissue Regenix Group's mailing address is Innovation Way, YORK, YO10 5NY, United Kingdom. The company can be reached via phone at +44-1904-567609.


MarketBeat Community Rating for Tissue Regenix Group (TRX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  106 (Vote Outperform)
Underperform Votes:  81 (Vote Underperform)
Total Votes:  187
MarketBeat's community ratings are surveys of what our community members think about Tissue Regenix Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tissue Regenix Group (LON:TRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.502.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 39GBX 39GBX 39GBX 39

Tissue Regenix Group (LON:TRX) Consensus Price Target History

Price Target History for Tissue Regenix Group (LON:TRX)

Tissue Regenix Group (LON:TRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
7/21/2017Jefferies GroupReiterated RatingBuyGBX 39View Rating Details
6/5/2017Beaufort SecuritiesReiterated RatingSpeculative BuyView Rating Details
(Data available from 2/19/2016 forward)

Earnings

Earnings History for Tissue Regenix Group (LON:TRX)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Tissue Regenix Group (LON:TRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Tissue Regenix Group (LON:TRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Tissue Regenix Group (LON TRX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Tissue Regenix Group (LON:TRX)

Tissue Regenix Group (LON TRX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/9/2017John Andrew SamuelInsiderBuy2,000,000GBX 10£200,000
(Data available from 1/1/2013 forward)

Headlines

Tissue Regenix Group (LON TRX) News Headlines

Source:
DateHeadline
Is Now The Time To Bet On The Healthcare Sector And Tissue Regenix Group plc (LON:TRX)?Is Now The Time To Bet On The Healthcare Sector And Tissue Regenix Group plc (LON:TRX)?
finance.yahoo.com - February 7 at 8:24 AM
Want To Invest In Tissue Regenix Group plc (LON:TRX)? Here’s How It Performed LatelyWant To Invest In Tissue Regenix Group plc (LON:TRX)? Here’s How It Performed Lately
finance.yahoo.com - January 30 at 8:27 AM
Is Tissue Regenix Group plc (AIM:TRX) As Financially Strong As Its Balance Sheet Indicates?Is Tissue Regenix Group plc (AIM:TRX) As Financially Strong As Its Balance Sheet Indicates?
finance.yahoo.com - December 11 at 11:48 AM
Tissue Regenix Chief Financial Officer Resigns, Says Trading In LineTissue Regenix Chief Financial Officer Resigns, Says Trading In Line
www.morningstar.co.uk - December 1 at 6:20 PM
Have Investors Already Priced In Tissue Regenix Group plc’s (AIM:TRX) Growth?Have Investors Already Priced In Tissue Regenix Group plc’s (AIM:TRX) Growth?
finance.yahoo.com - November 20 at 11:25 AM
Tissue Regenix Taps Non-Executive Director Steve Couldwell As New CEOTissue Regenix Taps Non-Executive Director Steve Couldwell As New CEO
www.morningstar.co.uk - November 2 at 10:06 AM
CellRight Technologies to Participate in Worlds Largest Spine Exhibition - Business Wire (press release)CellRight Technologies to Participate in World's Largest Spine Exhibition - Business Wire (press release)
www.businesswire.com - October 24 at 3:33 PM
CellRight Technologies to Participate in World’s Largest Spine ExhibitionCellRight Technologies to Participate in World’s Largest Spine Exhibition
finance.yahoo.com - October 24 at 3:32 PM
Tissue Regenix Trading In Line As CEO Antony Odell Steps DownTissue Regenix Trading In Line As CEO Antony Odell Steps Down
www.morningstar.co.uk - October 19 at 10:05 AM
Should You Be Holding Tissue Regenix Group plc (AIM:TRX) Right Now?Should You Be Holding Tissue Regenix Group plc (AIM:TRX) Right Now?
finance.yahoo.com - October 6 at 11:47 AM
Tissue Regenix Revenue Jumps On Dermapure And GBM-V; Loss Stays FlatTissue Regenix Revenue Jumps On Dermapure And GBM-V; Loss Stays Flat
www.morningstar.co.uk - September 29 at 11:38 AM
What Are The Drivers Of Tissue Regenix Group plc’s (AIM:TRX) Risks?What Are The Drivers Of Tissue Regenix Group plc’s (AIM:TRX) Risks?
finance.yahoo.com - September 20 at 10:21 AM
Tissue Regenix Completes Acquisition of CellRight Technologies - Business Wire (press release)Tissue Regenix Completes Acquisition of CellRight Technologies - Business Wire (press release)
www.businesswire.com - August 10 at 8:55 AM
John Andrew Samuel Purchases 2,000,000 Shares of Tissue Regenix Group PLC (TRX) StockJohn Andrew Samuel Purchases 2,000,000 Shares of Tissue Regenix Group PLC (TRX) Stock
www.americanbankingnews.com - August 9 at 10:32 AM
Tissue Regenix Completes Acquisition of CellRight TechnologiesTissue Regenix Completes Acquisition of CellRight Technologies
finance.yahoo.com - August 9 at 8:29 AM
Tissue Regenix Completes Acquisition of CellRight TechnologiesTissue Regenix Completes Acquisition of CellRight Technologies
finance.yahoo.com - August 9 at 8:29 AM
Tissue Regenix Group PLCs (LON:TRX) "Buy" Rating Reiterated at Jefferies Group LLCTissue Regenix Group PLC's (LON:TRX) "Buy" Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - July 22 at 11:22 PM
Tissue Regenix raises 40 mln stg to buy U.S. regenerative medicine firmTissue Regenix raises 40 mln stg to buy U.S. regenerative medicine firm
finance.yahoo.com - July 22 at 9:52 AM
Tissue Regenix In Talks To Buy US Regenerative Medicine Firm CellRightTissue Regenix In Talks To Buy US Regenerative Medicine Firm CellRight
www.morningstar.co.uk - May 19 at 1:18 PM
Tissue Regenixs DermaPure Gets Contract In US With VizientTissue Regenix's DermaPure Gets Contract In US With Vizient
www.morningstar.co.uk - March 2 at 9:00 AM
Tissue Regenix Hires Paul Devlin As New Finance DirectorTissue Regenix Hires Paul Devlin As New Finance Director
www.morningstar.co.uk - January 6 at 6:16 AM
Is this stock a buy after reporting a 150% increase in revenue?Is this stock a buy after reporting a 150% increase in revenue?
uk.finance.yahoo.com - October 12 at 10:55 AM
Tissue Regenix Group plc: DermaPure® - Two Peer Reviewed Clinical Papers PublishedTissue Regenix Group plc: DermaPure® - Two Peer Reviewed Clinical Papers Published
uk.finance.yahoo.com - September 15 at 11:31 AM
Tissue Regenix to feature via Discovery ChannelTissue Regenix to feature via Discovery Channel
uk.finance.yahoo.com - July 21 at 6:09 AM
Tissue Regenix Makes OrthoPure Progress In Europe And USTissue Regenix Makes OrthoPure Progress In Europe And US
www.morningstar.co.uk - July 11 at 7:48 PM
Tissue Regenix Appoints Orthopedic Clinical Advisory Board in the USTissue Regenix Appoints Orthopedic Clinical Advisory Board in the US
uk.finance.yahoo.com - July 5 at 9:24 AM

SEC Filings

Tissue Regenix Group (LON:TRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Tissue Regenix Group (LON TRX) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.